Today’s top gainers include the company GlaxoSmithKline plc (NYSE:GSK) which is in the industry Drug Manufacturers – Major, gaining -1.09% today. In the last week its performance is 0.80%, and 3.85% for the past quarter. Currently, GlaxoSmithKline plc, GSK has a target price of 47, so today’s gain of -1.09% is a significant step towards its target price. The GAP today is therefore -0.52%.
GlaxoSmithKline plc (NYSE:GSK), has a market cap of 104727.35, and is based in United Kingdom. Insider ownership is at 0.20%, and institutional ownership is 8.60%.
At the current price of 43.62, it has a dividend yield of 5.03%, and its target price is 47. This is with a profit margin of 2.50%, and total debt/equity of 6.05. GlaxoSmithKline plc (NYSE:GSK) has a P/E of 132.04, as well as a forward P/E of 16.87.
With a current EPS of 0.33, and a forecasted EPS growth for next year at 14.35%,GlaxoSmithKline plc (NYSE:GSK) has had a EPS growth for the past five years at 40.20%. For the next five years EPS growth is projected to be 0.60%.
Performance for the year is 11.15%. Since its IPO date on 7/9/1986, the total performance to date is 14.26%.
Volume today for GlaxoSmithKline plc (NYSE:GSK), is 2236491, while its average volume is 3462.05. Whilst the total gain today was -1.09%, it did have a day high of -1.56%.
Volatility for this week has been at 0.84%, and 1.33% for the month. The 52-week low for GlaxoSmithKline plc, GSK has been 24.19%, while the 52-week-high has reached -1.56%.
Looking at its return of investments, which is 41.40%, and its return on assets is 1.10%. GlaxoSmithKline plc (NYSE:GSK) has an operating margin of 7.50%. With a sales growth of 10.80% quarter over quarter. Bearing in mind that GlaxoSmithKline plc, GSK is in the sector Healthcare, its long-term debt/equity is 5.61, and has a current ratio of 1.1 and 0.8 for quick ratio.
So what is the value of GlaxoSmithKline plc? Well its PEG is 220.06, and the P/S is 3.2, along with a P/B of 28.45. Meanwhile it has a p/cash of 17.5.